Latest Insider Transactions at Pacira Bio Sciences, Inc. (PCRX)
This section provides a real-time view of insider transactions for Pacira Bio Sciences, Inc. (PCRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Pacira BioSciences, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Pacira BioSciences, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 03
2022
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
476
-1.05%
|
$26,180
$55.7 P/Share
|
|
Jul 11
2022
|
Paul J Hastings Director |
SELL
Open market or private sale
|
Direct |
533
-6.91%
|
$29,848
$56.95 P/Share
|
|
Jul 05
2022
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
924
-2.41%
|
$52,668
$57.19 P/Share
|
|
Jun 14
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.56%
|
$228,000
$38.35 P/Share
|
|
Jun 08
2022
|
Laura Brege Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+10.26%
|
-
|
|
Jun 08
2022
|
Christopher Christie Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+24.97%
|
-
|
|
Jun 08
2022
|
Yvonne Greenstreet Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+8.05%
|
-
|
|
Jun 08
2022
|
Paul J Hastings Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+13.07%
|
-
|
|
Jun 08
2022
|
Mark A. Kronenfeld Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+6.09%
|
-
|
|
Jun 08
2022
|
Gary W Pace Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+0.84%
|
-
|
|
Jun 08
2022
|
Mark Froimson Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,160
+16.05%
|
-
|
|
Jun 08
2022
|
Daryl Gaugler Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,900
+22.98%
|
-
|
|
Jun 08
2022
|
Dennis Mc Loughlin Chief Customer Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+16.66%
|
-
|
|
Jun 08
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+28.49%
|
-
|
|
Jun 08
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+21.69%
|
-
|
|
Jun 08
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
4,937
-4.23%
|
$296,220
$60.57 P/Share
|
|
Jun 08
2022
|
Max Reinhardt President, Rest of World |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+19.78%
|
-
|
|
Jun 08
2022
|
Charles A. Reinhart Iii Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,950
+17.99%
|
-
|
|
Jun 08
2022
|
Lauren Bullaro Riker Senior Vice President, Finance |
BUY
Grant, award, or other acquisition
|
Direct |
5,850
+22.76%
|
-
|
|
Jun 08
2022
|
Jonathan Slonin Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+20.63%
|
-
|
|
Jun 08
2022
|
Kristen Marie Williams Chief Administrative Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+29.6%
|
-
|
|
Jun 08
2022
|
Roy Winston Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,900
+18.01%
|
-
|
|
Jun 08
2022
|
David M Stack CEO and Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
21,500
+11.61%
|
-
|
|
Jun 08
2022
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
13,828
-2.28%
|
$829,680
$60.68 P/Share
|
|
Jun 07
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
2,570
-9.16%
|
$151,630
$59.89 P/Share
|
|
Jun 07
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
2,433
-9.07%
|
$150,846
$62.0 P/Share
|
|
Jun 07
2022
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
4,649
-25.41%
|
$274,291
$59.51 P/Share
|
|
Jun 06
2022
|
Daryl Gaugler Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,106
-8.78%
|
$67,466
$61.37 P/Share
|
|
Jun 06
2022
|
Dennis Mc Loughlin Chief Customer Officer |
SELL
Open market or private sale
|
Direct |
2,140
-6.3%
|
$130,540
$61.37 P/Share
|
|
Jun 06
2022
|
Anthony Molloy Chief Lgl & Compliance Officer |
SELL
Open market or private sale
|
Direct |
2,980
-16.98%
|
$181,780
$61.37 P/Share
|
|
Jun 06
2022
|
Charles Anthony Laranjeira Chief Technical Officer |
SELL
Open market or private sale
|
Direct |
2,813
-8.37%
|
$171,593
$61.37 P/Share
|
|
Jun 06
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
2,817
-9.5%
|
$171,837
$61.37 P/Share
|
|
Jun 06
2022
|
Charles A. Reinhart Iii Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,516
-8.17%
|
$153,476
$61.37 P/Share
|
|
Jun 06
2022
|
Lauren Bullaro Riker Senior Vice President, Finance |
SELL
Open market or private sale
|
Direct |
1,150
-7.59%
|
$70,150
$61.37 P/Share
|
|
Jun 06
2022
|
Jonathan Slonin Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
362
-1.27%
|
$22,082
$61.37 P/Share
|
|
Jun 06
2022
|
Kristen Marie Williams Chief Administrative Officer |
SELL
Open market or private sale
|
Direct |
3,969
-17.82%
|
$242,109
$61.37 P/Share
|
|
Jun 06
2022
|
Roy Winston Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
17,546
-4.42%
|
$1,070,306
$61.96 P/Share
|
|
Jun 06
2022
|
Roy Winston Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+10.99%
|
$212,500
$34.38 P/Share
|
|
Jun 06
2022
|
David M Stack CEO and Chairman |
SELL
Open market or private sale
|
Direct |
11,965
-7.12%
|
$729,865
$61.37 P/Share
|
|
May 23
2022
|
Jonathan Slonin Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+6.54%
|
$104,000
$52.37 P/Share
|
|
May 09
2022
|
Mark Froimson Director |
SELL
Open market or private sale
|
Direct |
1,000
-16.93%
|
$59,000
$59.37 P/Share
|
|
Apr 28
2022
|
David M Stack CEO and Chairman |
BUY
Exercise of conversion of derivative security
|
Direct |
22,500
+11.81%
|
$225,000
$10.81 P/Share
|
|
Apr 21
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
9,824
-24.89%
|
$717,152
$73.25 P/Share
|
|
Apr 21
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+24.05%
|
$525,000
$42.54 P/Share
|
|
Apr 20
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
9,764
-26.58%
|
$712,772
$73.99 P/Share
|
|
Apr 20
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+25.39%
|
$525,000
$42.54 P/Share
|
|
Apr 19
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
9,321
-27.78%
|
$671,112
$72.25 P/Share
|
|
Apr 19
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+27.14%
|
$525,000
$42.54 P/Share
|
|
Apr 18
2022
|
Max Reinhardt President, Rest of World |
SELL
Open market or private sale
|
Direct |
8,941
-29.8%
|
$652,693
$73.55 P/Share
|
|
Apr 18
2022
|
Max Reinhardt President, Rest of World |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+29.41%
|
$525,000
$42.54 P/Share
|